Sodium Glucose Co-transporter Inhibitors in Patients with Acromegaly and Diabetes
{{output}}
Acromegaly per se predisposes to diabetes. Somatostatin analogs (SSAs) have an overall neutral effect on glycemic control. However, a marked increase in hyperglycemia was observed recently since the introduction of pasireotide long-acting release (PAS-LAR). So... ...
